Molecularly Engineered Phenoxazinone‐Skeleton Cascade‐Activated NIR Probes for Monitoring Fe 2+ /Viscosity in Ferroptosis‐Mediated Parkinson's Disease
Source abstract
Abstract
ABSTRACT Parkinson's disease (PD) is the second most common neurodegenerative disease, in which ferroptosis may be the crucial event leading to dopaminergic neuron death. Accumulated ferrous ions (Fe 2+ ) and increased intracellular viscosity promote of ferroptosis. Precisely monitoring Fe 2+ /Viscosity, especially in ferroptosis, is crucial for PD theranostic. However, a feasible strategy is lacking. In this study, series of Fe 2+ /Viscosity cascade‐activated near‐infrared fluorescence probes (NP1–5) are synthesized. Through optical characterization and theoretical calculations, NP3 is selected as the optimal probe to monitor Fe 2 + /Viscosity via redox reactions and twisted intramolecular charge transfer processes. To verify this concept in the context of ferroptosis intervention in PD, an innovative nanoplatform is constructed based on NP3 and quercetin, modified with rabies virus glycoprotein‐29 and defined as PQR nanoparticles (PQR NPs). In vitro and in vivo experiments demonstrate that PQR NPs not only alleviate ferroptosis‐induced loss of dopaminergic neurons by reducing oxidative stress and neuroinflammation, mitigating α‐synuclein aggregation, and restoring mitochondrial function, but also could monitor the elevated Fe 2 + /Viscosity in ferroptosis of PD models. Present study developed a facile tool for monitoring Fe 2+ /Viscosity in ferroptosis. The findings have strong application potential in theranostics of PD and other ferroptosis related diseases.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Ferroptosis and cancer prognosis · Molecular Sensors and Ion Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Third Hospital of Shanxi Medical University Shanxi Bethune Hospital Taiyuan P. R. China
School of Basic Medical Sciences Shanxi Medical University Taiyuan P. R. China
Department of Chemical and Materials Engineering Lyuliang University Lvliang P. R. China
Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore
Funding
National Natural Science Foundation of China · Shanxi Scholarship Council of China
References (55)
Show source-provided references
1. 10.1136/bmj.r35010.1136/bmj.r350 ↗
2. 10.1007/s00415‐025‐13030‐210.1007/s00415‐025‐13030‐2 ↗
3. 10.1227/01.NEU.0000249209.11967.CB10.1227/01.NEU.0000249209.11967.CB ↗
4. 10.3389/fnagi.2023.121616310.3389/fnagi.2023.1216163 ↗
5. 10.1038/s41598‐023‐44322‐010.1038/s41598‐023‐44322‐0 ↗
6. 10.1007/s00415‐012‐6428‐310.1007/s00415‐012‐6428‐3 ↗
7. 10.1038/s41591‐021‐01382‐x10.1038/s41591‐021‐01382‐x ↗
8. 10.1016/j.snb.2024.13710410.1016/j.snb.2024.137104 ↗
9. 10.1016/j.snr.2025.10030510.1016/j.snr.2025.100305 ↗
10. 10.1016/j.cclet.2024.11017010.1016/j.cclet.2024.110170 ↗
11. 10.1016/j.bios.2023.11552110.1016/j.bios.2023.115521 ↗
12. 10.1016/j.ejmech.2024.11619510.1016/j.ejmech.2024.116195 ↗
13. 10.1039/D0TB01146K10.1039/D0TB01146K ↗
14. 10.1021/acs.jmedchem.1c0091010.1021/acs.jmedchem.1c00910 ↗
15. 10.1038/s41570‐021‐00277‐210.1038/s41570‐021‐00277‐2 ↗
16. 10.1016/j.molmed.2022.02.00310.1016/j.molmed.2022.02.003 ↗
17. 10.1097/MD.000000000004121810.1097/MD.0000000000041218 ↗
18. 10.1038/s41593‐022‐01221‐310.1038/s41593‐022‐01221‐3 ↗
19. 10.1016/j.trac.2023.11732710.1016/j.trac.2023.117327 ↗
20. 10.1039/D1CS01167G10.1039/D1CS01167G ↗
21. 10.1007/s11064‐021‐03262‐910.1007/s11064‐021‐03262‐9 ↗
22. 10.1007/s00702‐020‐02192‐010.1007/s00702‐020‐02192‐0 ↗
23. 10.1016/j.neuro.2021.11.00310.1016/j.neuro.2021.11.003 ↗
24. 10.1016/j.arr.2023.10203210.1016/j.arr.2023.102032 ↗
25. 10.1002/asia.20240005610.1002/asia.202400056 ↗
26. 10.1016/j.bios.2025.11747310.1016/j.bios.2025.117473 ↗
27. 10.1007/s12035‐023‐03827‐510.1007/s12035‐023‐03827‐5 ↗
28. 10.1111/cns.7064810.1111/cns.70648 ↗
29. 10.1155/2022/776935510.1155/2022/7769355 ↗
30. 10.3389/fphar.2021.66503110.3389/fphar.2021.665031 ↗
31. 10.31083/j.fbl280304210.31083/j.fbl2803042 ↗
32. 10.1186/s12951‐021‐01059‐010.1186/s12951‐021‐01059‐0 ↗
33. 10.15212/bioi‐2025‐007310.15212/bioi‐2025‐0073 ↗
34. 10.3390/antiox1401004910.3390/antiox14010049 ↗
35. 10.1016/j.jconrel.2025.01.02210.1016/j.jconrel.2025.01.022 ↗
36. 10.1016/j.cej.2023.14269710.1016/j.cej.2023.142697 ↗
37. 10.1021/acs.analchem.1c0528810.1021/acs.analchem.1c05288 ↗
38. 10.1016/j.dyepig.2021.10933710.1016/j.dyepig.2021.109337 ↗
39. 10.1016/j.bios.2025.11729010.1016/j.bios.2025.117290 ↗
40. 10.1002/adfm.20190327810.1002/adfm.201903278 ↗
41. 10.1039/D0CS00671H10.1039/D0CS00671H ↗
42. 10.5923/j.materials.20170702.0210.5923/j.materials.20170702.02 ↗
43. 10.1002/asia.20250013610.1002/asia.202500136 ↗
44. 10.1021/acs.jpclett.9b0002610.1021/acs.jpclett.9b00026 ↗
45. 10.1007/s43673‐023‐00114‐210.1007/s43673‐023‐00114‐2 ↗
46. 10.1016/j.cell.2012.03.04210.1016/j.cell.2012.03.042 ↗
47. 10.1016/j.snb.2023.13459410.1016/j.snb.2023.134594 ↗
48. 10.3390/molecules2406112310.3390/molecules24061123 ↗
49. 10.1016/j.devcel.2024.09.00410.1016/j.devcel.2024.09.004 ↗
50. 10.1016/j.colsurfb.2025.11458510.1016/j.colsurfb.2025.114585 ↗
51. 10.1007/s00702‐025‐02913‐310.1007/s00702‐025‐02913‐3 ↗
52. 10.1038/s41420‐022‐01183‐210.1038/s41420‐022‐01183‐2 ↗
53. 10.1002/med.2209110.1002/med.22091 ↗
54. 10.1007/s10571‐017‐0504‐210.1007/s10571‐017‐0504‐2 ↗
55. 10.7150/thno.8195110.7150/thno.81951 ↗